Harvard Bioscience Inc
HBIO
$8.00-3.73%
Delayed · as of Oct 16, 2026, 2:00 PM ET
Mkt cap
$20.26M
EV/Sales
0.55
P/E ratio
N/A
FY2025 Revenue
$86.55M
EPS (H1 2026)
$-1.41
Gross Margin (FY2025)
57.67%
Profit Margin (FY2025)
-65.51%
Beta
1.55
Div yield
N/A
Sector
Healthcare
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
Latest reported HBIO revenue for 2025-12-31 was $86.5M. Net income was -$56.7M. Revenue was down 8.1% from 2024-12-31 to 2025-12-31. HBIO currently screens at market cap $20.3M.
Use this HBIO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full HBIO income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company in the Healthcare sector.
Latest cached Harvard Bioscience Inc (HBIO) revenue for Dec 31, 2025 was $86.5M. Net income was -$56.7M. Statements: https://lician.com/financials/hbio
Harvard Bioscience Inc (HBIO) market capitalization is $20.3M on the latest cached snapshot.
Harvard Bioscience Inc (HBIO) cached previous close $8.31; day range $8.00 – $8.35; volume 4,108. Session quote: https://lician.com/quote/hbio
Harvard Bioscience Inc (HBIO) latest cached earnings event is "HBIO earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached HBIO filing is 8-K · Aug 11, 2026. Filings: https://lician.com/sec/hbio